Xofigo (Radium-223) Therapy for Prostate Cancer | Minute Medical, Vienna

At Minute Medical, located in the medical heart of Vienna, we address a specific and painful challenge of advanced prostate cancer: bone metastases. While other systemic treatments circulate through the soft tissues, Xofigo (Radium-223) is a "bone-seeking" radiopharmaceutical. It is engineered to mimic calcium, traveling directly to the areas of the skeleton where cancer has triggered abnormal bone turnover. By choosing Minute Medical for this therapy, patients receive a potent alpha-emitter treatment in a private, boutique setting that prioritizes neurological comfort and skeletal integrity over the high-volume environment of a general hospital. The biological ingenuity of Radium-223 lies in its chemical similarity to calcium. When prostate cancer spreads to the bone, it creates areas of rapid, chaotic mineral growth. Xofigo identifies these "hot zones" and integrates itself into the new bone matrix. Once embedded, it releases high-energy alpha particles. Because alpha radiation has an incredibly short range, less than 100 micrometers, it delivers a lethal blow to the surrounding cancer cells while leaving the sensitive bone marrow largely untouched. This "micro-range" precision is the key to Xofigo’s ability to kill tumor cells without the severe blood-count suppression often seen with older forms of radiation. At Minute Medical, the Xofigo protocol is integrated into a comprehensive skeletal health strategy. Before your first injection, our nuclear medicine specialists perform a 99mTc-Bone scintigraphy or a PET/CT to confirm that the cancer is localized primarily in the bone. The treatment itself is a "lunchbreak" procedure: a simple intravenous injection administered over approximately one minute. Unlike beta-emitting isotopes, the alpha radiation from Xofigo does not easily exit the patient’s body, meaning there are no complex radiation-safety restrictions for your family or friends following the appointment. The clinical experience at our Vienna facility is designed to be low-stress and highly efficient. A standard course of Xofigo consists of six injections, each spaced four weeks apart. Between these sessions, we monitor your blood counts (hemoglobin, white cells, and platelets) rigorously to ensure your body is responding optimally. Many of our patients report a significant reduction in bone pain and an improved "quality of movement" after just the second or third cycle. This pain-relieving effect is a primary goal of the therapy, often allowing patients to reduce their reliance on heavy analgesic medications. Xofigo at Minute Medical is more than just an injection; it is a specialized intervention to protect your mobility and extend your life. By focusing the power of alpha radiation directly into the bone, we provide a sophisticated defense against the progression of metastatic prostate cancer, helping you stay active and independent.